|Day Low/High||0.79 / 0.82|
|52 Wk Low/High||0.60 / 1.95|
Citigroup retains the top spot on TheStreet's Stock Search list today. New entries to the list include Hewlett-Packard, Windstream and China Unicom Hong Kong.
Citigroup continues its reign in the top spot of TheStreet's Stock Search list today. New entries to the list include BB&T, Home Depot, Urban Outfitters, Cell Therapeutics and VMware.
A quick and dirty guide to important biotech events for the busy month of September.
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
Spectrum Pharma reports loss and greater expenses; year-ago quarter included $20.7M payment
This week, readers weigh in on Onyx Pharma's fund-raising, Savient's gout treatment and Spectrum's Fusilev.
A quick and dirty guide to upcoming FDA approval dates for biotech drugs.
Those who believe Bayer would want to buy Spectrum for the rights to Zevalin need a strong dose of reality.
Readers sound off on Discovery Labs, Micromet and BioDelivery.
Readers write in about Cell Therapeutics' fund-raising, Onyx's buyout chances, Hemispherx's latest activities, and Curis' venture with Roche.
Readers seek insight on Immunomedics, Discovery Labs and AMAG Pharmaceuticals.
Cell Therapeutics will have to hustle to reach the break-even point it recently predicted for its fourth quarter.
Readers weigh in on Spectrum Pharma, Cell Therapeutics and Geron, and force us to explain -- again -- TheStreet's rules on stock ownership.
For the fourth day in a row, Bank of America remains atop TheStreet.com's stock-search list. New entries to the list include Cell Therapeutics, Hemispherx Biopharma, Vanda Pharmaceuticals and China Unicom Hong Kong.
Readers seek guidance on Cubist Pharmaceuticals and Arena's new cash haul, and wax poetic about Cell Therapeutics.
Holders of more than half of Cell Therapeutics' debt chose not to accept the company's below-par bid for their notes.
Cell Therapeutics says exchange offer reduced debt by $54.8M
Cell Therapeutics is expected to disclose soon whether debtholders have accepted a tender offer to exchange cash and company stock for their notes.
Bank of America claims the top spot on TheStreet.com's stock-search list today. New entries to the list include TriQuint Semiconductor, Huntington Bancshares Inc, Palm and Dolby Laboratories.
Cell Therapeutics shares surge after biotech firm says it may be listed on Russell 3000 Index
Bank of America and Citigroup are holding the top spots on TheStreet.com's stock-search list today. New entries to the list include Cell Therapeutics, ARYx Therapeutics, Hemispherx Biopharma and Boeing.
Bank of America claimed the top spot on TheStreet.com's stock-search list today. Newcomers to the list are Hemispherx Biopharma, Boeing, Cell Therapeutics, Joy Global and BE Aerospace.
Readers chime in on Hemispherx, Genxyme, ASCO, Cell Therapeutics and Cardiome.
Cell Therapuetics is working overtime to make its stock more appealing to debt holders.
A brilliantly crafted press release sends Cell Therapeutics rocketing despite data showing heart toxicity in pixantrone.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.